]>
IRCT20141209020258N130 IRCT 2020-01-20 Arak University of Medical Sciences comparing the effect ofKetamin; Bupivacain and Dexmedetomidine intraperitoneal in controlling the pain after operation in patients are candidates for abdominal hysterectomy Comparing the effect of Ketamin ; Bupivacain and Dexmedetomidine intraperitoneal in controlling the pain after operation in patients are candidates for abdominal hysterectomy 2019-01-10 anticipated 105 Complete https://irct.ir/trial/44886 interventional Randomization: Randomized, Blinding: Double blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: Simple individual randomization with randomization with envelopes in three groups A and B and C. In this method, we selected a number of cards or letters as an intervention group and the same ‎number of cards for the control group, then the cards were merged. One card was taken out and its ‎allocation was registered and the card was returned to the other cards after leaving. Then the cards ‎are merged again and we remove another card. This process continues to reach a random sequence ‎according to sample size, Blinding description: This study is double blind. Researcher who complete questionnaire and analyzer are blind (double blind). Outcome assessor and analyzer don't aware from grouping.The person evaluating the outcome is unaware of the grouping. Groups A and B and C are available to analyzer and outcome assessor. 2 abdominal hysterectomy. Intervention 1: Intervention group 1: The first group will be injected with 0.5 to 0.7 microgram in kilogram dexmedetomidine intraperitoneal. Intervention 2: Intervention group2: The second group will be injected 20-15 milligram bupivacaine intraperitoneal. Intervention 3: Intervention group3: The third group will be injected 75-50 milligram ketamin intraperitoneal. Yes - There is a plan to make this available What will be shared: When we publish article in journal When: After the article is published To whom: Researcher in university Conditions: If there are additional questions Where to obtain: Dr Shokrpour How to obtain: They have to write letters to the professors and the university Comments:
public Dr Alireza Kamali
Valiasr Hospital, Valiasr squre, Shahid Shirodi street
Arak Iran (Islamic Republic of) 3814957558 +98 68 3222 2003 alikamaliir@yahoo.com Arak University of Medical Sciences scientific Dr Maryam Shokrpour
Taleghani hospital, Emam khomeini street
Arak Iran (Islamic Republic of) 3814957558 +98 86 3222 2003 shokrpour@arakmu.ac.ir Arak University of Medical Sciences Iran (Islamic Republic of) All patients are candidates for abdominal hysterectomy ASA class 1 and 2 Age 30 to 70 years No sensitivity to drugs 30 years 70 years Female Emergency patients Dissatisfaction N99.3 Prolapse of vaginal vault after hysterectomy Treatment - Drugs Treatment - Drugs Treatment - Drugs Intervention group 1: The first group will be injected with 0.5 to 0.7 microgram in kilogram dexmedetomidine intraperitoneal Intervention group2: The second group will be injected 20-15 milligram bupivacaine intraperitoneal. Intervention group3: The third group will be injected 75-50 milligram ketamin intraperitoneal. Pain. Timepoint: Recovery, 2, 4, 8, 12 and 24 hours after surgery. Method of measurement: Visual analogue of pain. Amount of drug used. Timepoint: 24 hours after surgery. Method of measurement: Milligram. Arak University of Medical Sciences Approved 2018-12-30 Ethics comittee of Arak University of Medical Sciences Ethics comittee, Research center, Payambar Azam complex, Basij squre ,Sardasht,Arak Arak Markazi Iran (Islamic Republic of)